The invention relates to pyrido[3,2-e]pyrazines, to processes for preparing them, to pharmaceutical compositions which comprise these compounds and to the pharmaceutical use of these compounds, which are inhibitors of phosphodiesterase 10, as active compounds for treating central nervous system disorders, obesity, and metabolic disorders.
这项发明涉及
吡啶并[3,2-e]
吡嗪化合物,涉及其制备方法,包括这些化合物的药物组成物以及这些化合物的药用,这些化合物是
磷酸二酯酶10的
抑制剂,作为治疗中枢神经系统疾病、肥胖和代谢紊乱的活性化合物。